DeepMed Research

Nanjing Medical University First Hospital

🇨🇳China

Country: 🇨🇳China

Ownership: -

Employees: -

Market Cap: -

Website

Clinical Trials

TAVR for Aortic Valve Disease

Recruiting

Conditions: Aortic Valve Disease

Interventions: Device: transcatheter heart valve

First Posted Date: 2022-06-30

Last Posted Date: 2024-11-15

Lead Sponsor: Nanjing First Hospital, Nanjing Medical University

Target Recruit Count: 5000

Registration Number: NCT05439863

Locations: 🇨🇳
Nanjing First Hospital, Nanjing, Jiangsu, China

Different Treatment Strategies on Prognosis of Acute Ischemic Stroke(AISDTS)

Recruiting

Conditions: Ischemic Stroke

First Posted Date: 2022-06-08

Last Posted Date: 2024-11-22

Lead Sponsor: Nanjing First Hospital, Nanjing Medical University

Target Recruit Count: 5000

Registration Number: NCT05410457

Locations: 🇨🇳
Nanjing First Hospital, Nanjing Medical University, Nanjing, Jiangsu, China

Helicobacter Pylori 23S rRNA/gyrA Gene Mutation Detection Kit (Fluorescence PCR Fusion Curve Method)

Completed

Conditions: Fecal Drug Resistance Gene Detection
Helicobacter Pylori Infection, Susceptibility to
Helicobacter Pylori gyrA Levofloxacin Resistance Mutation
Helicobacter Pylori Infection

Interventions: Diagnostic Test: Sanger Sequencing group
Diagnostic Test: Bacterial culture and drug sensitivity test of gastric mucosa samples
Diagnostic Test: Detection of fecal samples with diagnostic kit

First Posted Date: 2022-06-08

Last Posted Date: 2024-01-30

Lead Sponsor: Nanjing First Hospital, Nanjing Medical University

Target Recruit Count: 1176

Registration Number: NCT05410652

Locations: 🇨🇳
The First Affiliated Hospital of Zhejiang Chinese Medical University, Hangzhou, Zhejiang, China
🇨🇳
Jiangsu Taizhou People's Hospital, Taizhou, Jiangsu, China
🇨🇳
The First Affiliated Hospital of Nanchang University, Nanchang, Jiangxi, China

and more 1 locations

The Roles of IL-9/E-cadherin and Ferroptosis in Intestinal Mucosal Barrier Injury in Sepsis

Conditions: Ferroptosis
Sepsis
Intestinal Mucosal Barrier

Interventions: Procedure: Standard treatments for sepsis

First Posted Date: 2022-06-08

Last Posted Date: 2022-06-08

Lead Sponsor: Nanjing First Hospital, Nanjing Medical University

Target Recruit Count: 100

Registration Number: NCT05410665

Locations: 🇨🇳
Nanjing First Hospital, Nanjing, Jiangsu, China

Improving Blood Lipid Management in Symptomatic Intracranial Atherosclerotic Stenosis on Clinical Outcome

Not Applicable

Recruiting

Conditions: Intracranial Artery Stenosis

Interventions: Drug: PCSK9 inhibitor

First Posted Date: 2022-05-31

Last Posted Date: 2024-11-15

Lead Sponsor: Nanjing First Hospital, Nanjing Medical University

Target Recruit Count: 180

Registration Number: NCT05397405

Locations: 🇨🇳
Nanjing First Hospital, Nanjing, Jiangsu, China
🇨🇳
Nanjing First Hospital, Nanjing Medical University, Nanjing, Jiangsu, China

Research on Optimal Diagnosis and Treatment of Cardiorenal Syndrome

Recruiting

Conditions: Heart Failure
Coronary Heart Disease
Kidney Injury
Kidney Diseases
Heart Valve Diseases
Dialysis; Complications

Interventions: Other: guideline recommended routine treatment

First Posted Date: 2022-05-31

Last Posted Date: 2022-06-02

Lead Sponsor: Nanjing First Hospital, Nanjing Medical University

Target Recruit Count: 1200

Registration Number: NCT05397392

The Effect of Blood Flow Restriction Training on the Patients of Distal Radius Fracture

Not Applicable

Completed

Conditions: Distal Radius Fracture

Interventions: Other: Blood flow restriction combined with traditional rehabilitation training
Other: Traditional rehabilitation training

First Posted Date: 2022-05-12

Last Posted Date: 2022-05-12

Lead Sponsor: Nanjing First Hospital, Nanjing Medical University

Target Recruit Count: 25

Registration Number: NCT05371431

Locations: 🇨🇳
Nanjing First Hospital, Nanjing, Jiang Su, China

National Registry and Cohort Study of Pulmonary Vascular Disease

Recruiting

Conditions: Pulmonary Arterial Hypertension

Interventions: Combination Product: The clinical course and disease management

First Posted Date: 2022-05-10

Last Posted Date: 2024-07-03

Lead Sponsor: Nanjing First Hospital, Nanjing Medical University

Target Recruit Count: 1000

Registration Number: NCT05368467

Locations: 🇨🇳
Nanjing First Hospital, Nanjing, Jiangsu, China
🇨🇳
Guangdong Provincial Peoples Hospital, Guangzhou, Guangdong, China
🇨🇳
General Hospital of Tianjin Medical University, Tianjin, Tianjin, China

and more 10 locations

Safety and Efficacy of POT PTCA Balloon Dilatation Catheter for the Optimal Dilation After DES Implantation

Not Applicable

Completed

Conditions: Coronary Artery Disease

Interventions: Procedure: Balloon dilation

First Posted Date: 2022-05-10

Last Posted Date: 2024-03-21

Lead Sponsor: Nanjing First Hospital, Nanjing Medical University

Target Recruit Count: 48

Registration Number: NCT05368129

Locations: 🇨🇳
Nanjing First Hospital, Nanjing, Jiangsu, China

The Different Response of Endocrine Hormones to Hypoglycemia in Patients With Type 1 or Type 2 Diabetes

Completed

Conditions: Diabetes

Interventions: Diagnostic Test: The hyperinsulinaemic hypoglycaemic clamp

First Posted Date: 2022-03-22

Last Posted Date: 2023-05-31

Lead Sponsor: Nanjing First Hospital, Nanjing Medical University

Target Recruit Count: 35

Registration Number: NCT05290207

Locations: 🇨🇳
Nanjing First Hospital, Nanjing Medical Univesity, Nanjing, China

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy